Дата: 2008-10-17 11:35
???????? ?????????? ????????????

* A
* ACCOMPLISH - Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension
* ACTION - A Coronary disease Trial Investigating Outcome with Nifedipine GITS
* ADVANCE - Action in Diabetes and Vascular disease: Preterax and Diamicron-MR Controlled Evaluation
* AFCAPS - Air Force Coronary Atherosclerosis Prevention Study
* AIRE - Acute Infarction Ramipril Effi cacy
* ALLHAT - Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
* ASCOT - Anglo-Scandinavian Cardiac Outcomes Trial
* ASCOT-BPLA - Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm
* Australian National BP Study - Australian National Blood Pressure Study
* B
* BBHAT - Beta Blocker Heart Attack Trial
* BIMS - Bisoprolol International Multicenter Study
* C
* CAPRIE - Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events
* CARDS - Collaborative Atorvastatin Diabetes Study
* CAST - Cardiac Arrhythmia Suppression Trial
* CCS-1 - Chinese Cardiac Study 1
* CHARM - Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity
* COMMIT - ClOpidogrel and Metoprolol in Myocardial Infarction Trial
* CONSENSUS-2 - 2nd Cooperative New Scandinavian Enalapril Survival Study
* CORONA - Controlled Rosuvastatin in Multinational Trial in Heart Failure
* D
* DAVIT II - Danish Verapamil Infarction Trial II
* E
* EHS - Euro Heart Survey
* ELITE-2 - Evaluation of Losartan in the Elderly II
* EMIP-FR - European Myocardial Infarction Project - Free Radicals
* EUROPA - EUropean trial on Reduction Of cardiac events with Perindopril in patients with stable coronary Artery disease
* F
* FDA - Food and Drug Administration (US)
* FIELD - Fenofi brate Intervention and Event Lowering in Diabetes
* G
* GISSI-3 - Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarcto Miocardico 3
* GISSI-HF - Gruppo Italiano per lo Studio della Sopravvivenza nell'Insuffi cienza Cardiaca Heart Failure Study
* GRACE - Global Registry of Acute Coronary Events
* H
* HAPPHY - Heart Attack Primary Prevention in Hypertension
* HDFP - Hypertension Detection and Follow-up Program
* HINT - Holland University Nifedipine/metoprolol Trial
* HOPE - Heart Outcomes Prevention Evaluation
* HPS - MRC/BHF Heart Protection Study
* I
* IDNT - Irbesartan in Diabetic Nephropathy Trial
* INTER-ARS - Comparison of the effi cacy and safety of generic atorvastatin versus original atorvastatin in the patients of high coronary risk with hyperlipidemia
* INVEST - International Verapamil SR/Trandolapril Study
* IONA - Impact Of Nicorandil in Angina
* IPPPSH - International Prospective Primary Prevention Study in Hypertension
* ISIS-4 - Fourth International Study of Infarct Survival
* L
* LIFE - Losartan Intervention For Endpoint
* Reduction in Hypertension Study
* LIPID - Long-term Intervention with Pravastatin in Ischemic Disease
* M
* MAPHY - Primary Prevention Metoprolol in Patients with Hypertension
* MDPIT - Multicenter Diltiazem Post-Infarction Trial
* METEOR - Measuring Effects on Intima-Media Thickness: an Evaluation of Rosuvastatin
* MOSES - Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention
* MRC - Medical Research Council study MRC Old - Medical Research Council trial of treatment of hypertension in older adults
* MRFIT - Multiple Risk Factor Intervention Trial
* N
* NORDIL - Randomised trial of effects of calcium antagonists compared with diuretics and b-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
* O
* ONTARGET - ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial
* OPTIMAAL - Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan
* ????? - ????????????? ? ??????????? ??????? ????????? ???????? ????? ? ???????? ??????????? ???????? 2005-2006 ??. (????????? ????? 2006)
* P
* PEACE - Prevention of Events with AngiotensinConverting Enzyme inhibitors
* PHARAO - The Prevention of Hypertension With the ACE-inhibitor Ramipril in Patients With High Normal Blood Pressure
* PRAISE - Prospective Randomized Amlodipine Survival Evaluation
* PROGRESS - Perindopril Protection Against Recurrent Stroke Study
* PROFESS - Prevention Regimen For Effectively avoiding Second Strokes
* PROVE IT - TIMI 22 - Pravastatin or Atorvastatin Evaluation and Infection Therapy - Thrombolysis in Myocardial Infarction 22
* Q
* QUIET - QUinapril Ischemic Event Trial
* R
* RALES - Randomized Aldactone Evaluation Study
* S
* SAVE - Survival and Ventricular Enlargement
* SENIORS - Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with HF
* SMILE - Survival of Myocardial Infarction Longterm Evaluation
* SPARCL - Stroke Prevention by Aggressive Reduction in Cholesterol Levels
* SPRINT-1 - Stroke Prevention in reversible Ischemia Trial
* SPRINT-2 - Secondary Prevention Reinfarction Israeli Nifedipine Trial II
* STOP-2 - Stroke Prevention in Sickle Cell Anemia II
* STOP-Hypertension 2 - Swedish Trial in Old Patients with Hypertension II
* STONE - Shanghai Trial of Nifedipine in the Elderly
* Syst-EUR - Systolic hypertension - Europe
* T
* TRACE - TRAndolapril Cardiac Evaluation
* TROPHY - TRial Of Preventing HYpertension
* U
* UK-PDS - UK Prospective Diabetes Study
* V
* VAHIT - Veterans Affairs High-Density Lipoprotein Intervention
* Val-HeFT - Valsartan Heart Failure Trial
* VALIANT - Valsartan in Acute Myocardial Infarction Trial
* VALUE - Valsartan Antihypertensive Long-term Use Evaluation
* W
* WOSCOPS - West of Scotland Coronary Prevention Study

Наверх страницы
[1] > 2 < [3] [4] [5] [6] [7] [8] [9] [10] [11] [12]